134 related articles for article (PubMed ID: 32668244)
1. The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming.
Cheng ZL; Zhang ML; Lin HP; Gao C; Song JB; Zheng Z; Li L; Zhang Y; Shen X; Zhang H; Huang Z; Zhan W; Zhang C; Hu X; Sun YP; Jiang L; Sun L; Xu Y; Yang C; Ge Y; Zhao Y; Liu X; Yang H; Liu P; Guo X; Guan KL; Xiong Y; Zhang M; Ye D
Cell Rep; 2020 Jul; 32(2):107877. PubMed ID: 32668244
[TBL] [Abstract][Full Text] [Related]
2. Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate.
Sardina JL; Collombet S; Tian TV; Gómez A; Di Stefano B; Berenguer C; Brumbaugh J; Stadhouders R; Segura-Morales C; Gut M; Gut IG; Heath S; Aranda S; Di Croce L; Hochedlinger K; Thieffry D; Graf T
Cell Stem Cell; 2018 Nov; 23(5):727-741.e9. PubMed ID: 30220521
[TBL] [Abstract][Full Text] [Related]
3. TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.
Secardin L; Limia CEG; di Stefano A; Bonamino MH; Saliba J; Kataoka K; Rehen SK; Raslova H; Marty C; Ogawa S; Vainchenker W; Monte-Mor BDCR; Plo I
Stem Cell Res; 2020 Apr; 44():101755. PubMed ID: 32193150
[TBL] [Abstract][Full Text] [Related]
4. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.
Costa Y; Ding J; Theunissen TW; Faiola F; Hore TA; Shliaha PV; Fidalgo M; Saunders A; Lawrence M; Dietmann S; Das S; Levasseur DN; Li Z; Xu M; Reik W; Silva JC; Wang J
Nature; 2013 Mar; 495(7441):370-4. PubMed ID: 23395962
[TBL] [Abstract][Full Text] [Related]
5. PRDM14 promotes active DNA demethylation through the ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells.
Okashita N; Kumaki Y; Ebi K; Nishi M; Okamoto Y; Nakayama M; Hashimoto S; Nakamura T; Sugasawa K; Kojima N; Takada T; Okano M; Seki Y
Development; 2014 Jan; 141(2):269-80. PubMed ID: 24335252
[TBL] [Abstract][Full Text] [Related]
6. Zscan4 is regulated by PI3-kinase and DNA-damaging agents and directly interacts with the transcriptional repressors LSD1 and CtBP2 in mouse embryonic stem cells.
Storm MP; Kumpfmueller B; Bone HK; Buchholz M; Sanchez Ripoll Y; Chaudhuri JB; Niwa H; Tosh D; Welham MJ
PLoS One; 2014; 9(3):e89821. PubMed ID: 24594919
[TBL] [Abstract][Full Text] [Related]
7. The oncogene Etv5 promotes MET in somatic reprogramming and orchestrates epiblast/primitive endoderm specification during mESCs differentiation.
Zhang J; Cao H; Xie J; Fan C; Xie Y; He X; Liao M; Zhang S; Wang H
Cell Death Dis; 2018 Feb; 9(2):224. PubMed ID: 29445086
[TBL] [Abstract][Full Text] [Related]
8. The necessity of ZSCAN4 for preimplantation development and gene expression of bovine embryos.
Takahashi K; Ross PJ; Sawai K
J Reprod Dev; 2019 Aug; 65(4):319-326. PubMed ID: 31019155
[TBL] [Abstract][Full Text] [Related]
9. Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylation.
Jia L; Wang Y; Wang C; Du Z; Zhang S; Wen X; Zhou L; Li H; Chen H; Li D; Zhang S; Li W; Xu W; Hoffman AR; Cui J; Hu JF
Nucleic Acids Res; 2020 Apr; 48(7):3935-3948. PubMed ID: 32055844
[TBL] [Abstract][Full Text] [Related]
10. Zygotic Genome Activation Revisited: Looking Through the Expression and Function of Zscan4.
Ko MS
Curr Top Dev Biol; 2016; 120():103-24. PubMed ID: 27475850
[TBL] [Abstract][Full Text] [Related]
11. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
[TBL] [Abstract][Full Text] [Related]
12.
Li XH; Sun MH; Jiang WJ; Zhou D; Lee SH; Heo G; Chen Z; Cui XS
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569497
[TBL] [Abstract][Full Text] [Related]
13. Rad50 mediates DNA demethylation to establish pluripotent reprogramming.
Park H; Cho B; Kim J
Exp Mol Med; 2020 Jul; 52(7):1116-1127. PubMed ID: 32665583
[TBL] [Abstract][Full Text] [Related]
14. Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming.
Zhu G; Li Y; Zhu F; Wang T; Jin W; Mu W; Lin W; Tan W; Li W; Street RC; Peng S; Zhang J; Feng Y; Warren ST; Sun Q; Jin P; Chen D
Stem Cell Reports; 2014 Mar; 2(3):253-61. PubMed ID: 24672749
[TBL] [Abstract][Full Text] [Related]
15. AKT signaling is associated with epigenetic reprogramming via the upregulation of TET and its cofactor, alpha-ketoglutarate during iPSC generation.
Sekita Y; Sugiura Y; Matsumoto A; Kawasaki Y; Akasaka K; Konno R; Shimizu M; Ito T; Sugiyama E; Yamazaki T; Kanai E; Nakamura T; Suematsu M; Ishino F; Kodera Y; Kohda T; Kimura T
Stem Cell Res Ther; 2021 Sep; 12(1):510. PubMed ID: 34563253
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-29 impairs the early phase of reprogramming process by targeting active DNA demethylation enzymes and Wnt signaling.
Fráguas MS; Eggenschwiler R; Hoepfner J; Schiavinato JLDS; Haddad R; Oliveira LHB; Araújo AG; Zago MA; Panepucci RA; Cantz T
Stem Cell Res; 2017 Mar; 19():21-30. PubMed ID: 28038351
[TBL] [Abstract][Full Text] [Related]
17. "TET-on" pluripotency.
Wang P; Qu J; Wu MZ; Zhang W; Liu GH; Izpisua Belmonte JC
Cell Res; 2013 Jul; 23(7):863-5. PubMed ID: 23732523
[TBL] [Abstract][Full Text] [Related]
18. Uncovering Sequence-Specific Transcription Factors Interacting with TET2.
Tian TV; Sardina JL
Methods Mol Biol; 2021; 2272():239-250. PubMed ID: 34009618
[TBL] [Abstract][Full Text] [Related]
19. ZSCAN4 is negatively regulated by the ubiquitin-proteasome system and the E3 ubiquitin ligase RNF20.
Portney BA; Khatri R; Meltzer WA; Mariano JM; Zalzman M
Biochem Biophys Res Commun; 2018 Mar; 498(1):72-78. PubMed ID: 29477841
[TBL] [Abstract][Full Text] [Related]
20. A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation.
Nishimura K; Aizawa S; Nugroho FL; Shiomitsu E; Tran YTH; Bui PL; Borisova E; Sakuragi Y; Takada H; Kurisaki A; Hayashi Y; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2017 Mar; 8(3):787-801. PubMed ID: 28262547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
